Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Therapy Oncolytics|October 14, 2015
Designing Herpes Viruses as OncolyticsCole Peters, Samuel D Rabkin
Molecular Therapy Oncolytics|October 19, 2020
Updates on Oncolytic Virus Immunotherapy for CancersCole Peters, Paola Grandi, Fares Nigim
Methods in Enzymology|March 4, 2020
Generation and validation of recombinant herpes simplex type 1 viruses (HSV-1) using CRISPR/Cas9 genetic disruptionPraveen K Bommareddy, Cole Peters, Howard L Kaufman
Journal of the National Cancer Institute|April 5, 2017
Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in GlioblastomaJianfang Ning, Hiroaki Wakimoto, Cole Peters, et al.
Journal of Virology|May 26, 2018
Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like CellsCole Peters, Max Paget, Kizito-Tshitoko Tshilenge, et al.
Journal for Immunotherapy of Cancer|May 8, 2023
Immunotherapy resistance driven by loss of NY-ESO-1 expression in response to transgenic adoptive cellular therapy with PD-1 blockadeLuke Frankiw, Arun Singh, Cole Peters, et al.
Pageof 1